Cargando…
Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth
Tumor growth and metastasis depend on angiogenesis. Thus, inhibiting tumor angiogenesis has become promising cancer therapeutic strategy in recent years. Tumstatin is a more powerful angiogenesis inhibitor than endostatin. Anti-angiogenic active fragment encoding amino acids 45–132 (Tum-5) of tumsta...
Autores principales: | He, Lian, Yang, Huijun, Liu, Fei, Chen, Yiyan, Tang, Sijia, Ji, Wei, Tang, Jianli, Liu, Zhudong, Sun, Yunjun, Hu, Shengbiao, Zhang, Youming, Liu, Xiong, Huang, Weitao, Ding, Xuezhi, Xia, Liqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689645/ https://www.ncbi.nlm.nih.gov/pubmed/29156755 http://dx.doi.org/10.18632/oncotarget.20486 |
Ejemplares similares
-
Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy
por: He, Lian, et al.
Publicado: (2019) -
E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy
por: Zhang, Yunlei, et al.
Publicado: (2018) -
Deciphering the Metabolic Pathway Difference Between Saccharopolyspora pogona and Saccharopolyspora spinosa by Comparative Proteomics and Metabonomics
por: Rang, Jie, et al.
Publicado: (2020) -
Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
por: Park, Jihye, et al.
Publicado: (2021) -
Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)